Exchanges
BSE, NSE
Industry
Specialty Chemicals
Issue
Book building

Kronox Lab Sciences IPO

₹159.32

+17.15% on listing

Listing-day close · NSE · 10 Jun 2024 · issue price ₹136

Kronox Lab Sciences’ ₹130 crore IPO was priced at ₹136 a share. It listed on the NSE on 10 Jun 2024 and closed its first day at ₹159.32, up 17.15% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹130 Cr
Fresh issue
—
Offer for sale
₹130 Cr
Lot size
110 shares
Minimum investment
₹14,960
Face value
₹10
Registrar
Kfin Technologies

Subscription

Kronox Lab Sciences IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—82.62×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹505 Cr
P/E (post-issue)
24.5
EPS (post-issue)
₹5.56
Price to book
8.4
ROE
25.66%
ROCE
33.15%
PAT margin
22.60%
Promoter holding
100.00% → 74.21%

Financials as of 31 Dec 2023, from the offer documents.

Listing

Listing date
10 Jun 2024
Issue price
₹136
Open
₹164.95
High
₹165.60
Low
₹156.70
Close
₹159.32

Listing day on the NSE. The close was +17.15% on the issue price.

KRONOX LAB SCIENCES share price today

FAQs

When did the Kronox Lab Sciences IPO open and close?

It opened on 3 Jun 2024 and closed on 5 Jun 2024.

What was the Kronox Lab Sciences IPO price?

The price band was ₹129–136 a share. The final issue price was ₹136.

What is the lot size and minimum investment?

One lot is 110 shares, ₹14,960 at ₹136 a share. Retail investors apply in whole lots.

How much did Kronox Lab Sciences raise?

₹130 crore: ₹130 crore offered by existing shareholders.

How many times was the Kronox Lab Sciences IPO subscribed?

82.62 times overall.

How did Kronox Lab Sciences list?

It listed on the NSE on 10 Jun 2024 at ₹164.95 and closed the day at ₹159.32, up 17.15% on the ₹136 issue price.

Who is the registrar of the Kronox Lab Sciences IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app